Iq-ai Ltd Share News (IQAI)

Iq-ai Ltd Information

Buy IQAI Shares
Add IQAI to Watchlist
Add IQAI to Alert

Share Price Information for Iq-ai Ltd (IQAI)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.65

Bid: 1.60

Ask: 1.70

Change: 0.00 (0.00%)

Spread: 0.10 (6.25%)

Open: 1.65

High: 1.90

Low: 1.65

Prev. Close: 1.65

Last checked at -

UK shareholder meetings calendar - next 7 days

Wed, 12th May 2021 16:04

Thursday 13 May
Access Intelligence PLC	AGM
Balfour Beatty PLC	AGM
Bould Opportunities PLC	GM re Cizzle Biotechnology acquisition
Conduit Holdings Ltd	AGM
ContourGlobal PLC	AGM
Direct Line Insurance Group PLC	AGM
Elementis PLC	AGM
Empresaria Group PLC	AGM
Eurocell PLC	AGM
Hiscox Ltd	AGM
IGas Energy PLC	AGM
John Wood Group PLC	AGM
Moneysupermarket.com Group PLC	AGM
Ocado Group PLC	AGM
Prudential PLC	AGM
Quilter PLC	AGM
Rolls-Royce Holdings PLC	AGM
Serinus Energy PLC	AGM
SIG PLC	AGM
Spire Healthcare Group PLC	AGM
TI Fluid Systems PLC	AGM
TT Electronics PLC	AGM
Unite Group PLC	AGM
Valeura Energy Inc	AGM
Friday 14 May
Derwent London PLC	AGM
DigitalBox PLC	AGM
Greggs PLC	AGM
John Menzies PLC	AGM
JPMorgan American Investment Trust PLC	AGM
Kistos PLC	GM re acquisition of Tulip Oil Netherlands
Phoenix Group Holdings PLC	AGM
Sabre Insurance Group PLC	AGM
St James's Place PLC	AGM
Tasty PLC	AGM
Wheaton Precious Metals Corp	AGM
Wishbone Gold PLC	AGM
Monday 17 May
Bahamas Petroleum Co PLC	EGM re share placing, name change
GCP Asset Backed Income Fund Ltd	AGM
Horizonte Minerals PLC	AGM
Vistry Group PLC	AGM
Tuesday 18 May
4imprint Group PLC	AGM
accesso Technology Group PLC	AGM
Cairn Homes PLC	AGM
Chaarat Gold Holdings Ltd	AGM
Chesnara PLC	AGM
Fidelity Japan Trust PLC	AGM
Forterra PLC	AGM
IQGeo Group PLC	AGM
Metro Bank PLC	AGM
Metro Bank PLC	AGM
Myanmar Strategic Holdings Ltd	AGM
Royal Dutch Shell PLC	AGM
Standard Life Aberdeen PLC	AGM
US Solar Fund PLC	AGM
Vivo Energy PLC	AGM
Wednesday 19 May
Alliance Pharma PLC	AGM
Arix Bioscience PLC	AGM
BlackRock Latin American Investment Trust PLC	AGM
Boku Inc	AGM
City Merchants High Yield Trust Ltd	GM re merger with Invesco Enhanced Income Ltd
Coats Group PLC	AGM
Diaceutics PLC	AGM
Dialight PLC	AGM
EKF Diagnostics Holdings PLC	AGM
Funding Circle Holdings PLC	AGM
IQ-AI Ltd	AGM
K3 Business Technology Group PLC	AGM
Keller Group PLC	AGM
Medica Group PLC	AGM
Pendragon PLC	AGM
Permanent TSB Group Holdings PLC	AGM
Plutus PowerGen PLC	AGM
PPHE Hotel Group Ltd	AGM
Regional REIT Ltd	AGM
Riverstone Credit Opportunities Income PLC	AGM
Safestyle UK PLC	AGM
Science Group PLC	AGM

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News

10 May 2024 15:14

IQ-AI subsidiary gets rare paediatric disease designation FDA

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary, Imaging Biometrics LLC, has been granted rare paediatric disease designation by the US Food & Drug Administration for its lead drug candidate, IB-003, or gallium maltolate for the treatment of ATRT.

2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

10 Jan 2024 11:48

IQ-AI falls after subsidiary notes launch of treatment access scheme

(Alliance News) - IQ-AI Ltd shares fell on Wednesday, after it said its subsidiary Imaging Biometrics LLC is launching an intermediate population cohort expanded access programme for oral gallium maltolate.

19 Dec 2023 17:00

IQ-AI firm gets US FDA fast-track status for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Tuesday said the US Food & Drug Administration has granted 'fast-track" designation for oral gallium maltolate, which is its subsidiary Imaging Biometrics LLC's therapeutic for the treatment of adult patients with relapsed or refractory glioblastoma.

5 Dec 2023 11:49

IQ-AI stock rises on positive interim results from glioblastoma trial

(Alliance News) - IQ-AI Ltd on Tuesday reported positive results from Phase 1 of an on-going study for its investigational monotherapy oral gallium maltolate.

8 Nov 2023 12:04

IQ-AI says Imaging Biometrics submits paediatric rare disease request

(Alliance News) - IQ-AI Ltd on Wednesday said its wholly-owned subsidiary Imaging Biometrics LLC has submitted a paediatric rare disease request to the US Food & Drug Administration for its gallium maltolate therapy.

18 Oct 2023 17:11

IN BRIEF: IQ-AI subsidiary "central" to "landmark" brain cancer study

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Notes its wholly-owned subsidiary, Imaging Biometrics LLC (IB), has announced the results of a "landmark" study. Says the study represents the first large-scale characterization of the invasive tumour margins of high-grade glioma using multi-regional genomic/transcriptomic sequencing with spatially matched MRI measurements in glioma. High-grade glioma is a deadly brain cancer. Explains that Imaging Biometrics' IB Neuro's dynamic susceptibility contrast magnetic resonance imaging software was central to the study.

9 Oct 2023 12:09

IN BRIEF: IQ-AI subsidiary wins orphan drug designation from US FDA

IQ-AI Ltd - St Helier, Jersey-based medical services firm focused on cancer treatment - Wholly-owned subsidiary Imaging Biometrics LLC is granted an orphan drug designation from the US Food & Drug Administration for gallium maltolate for the treatment of atypical teratoid rhabdoid tumour. Notes this is the second orphan designation granted to gallium maltolate this year.

8 Sep 2023 10:25

IQ-AI notes vindication of subsidiary's reduced gadolinium approach

(Alliance News) - IQ-AI Ltd on Friday noted that studies by its subsidiary Imaging Biometrics LLC validated the dosing approach of Imaging's MRI-focused IB Neuro.

18 Aug 2023 12:17

IQ-AI shares jump on subsidiary's GE Healthcare deal

(Alliance News) - IQ-AI Ltd on Friday said its wholly-owned subsidiary Imaging Biometrics LLC has signed a deal with GE HealthCare Technologies Inc.

17 Aug 2023 11:21

IQ-AI interim loss narrows amid higher revenue, lower expenses

(Alliance News) - IQ-AI Ltd on Thursday announced a slightly lower loss for the six months to June 30, as revenue was up and administrative expenses were lower.

19 Jul 2023 10:45

IN BRIEF: IQ-AI subsidiary's app adopted by US medical college

IQ-AI Ltd - Jersey-based medical services firm focused on cancer treatment - Says subsidiary Imaging Biometrics LLC's handheld application IB Nimble has been adopted by the Medical College of Wisconsin's Orthopedic Department for use in bone metastases treatment. IB Nimble's designer, Joseph Bovi, is professor of radiation oncology & neurosurgery at MCW. The application was originally designed to help treat brain metastases. IQ-AI says it "provides real-time collaboration amongst multi-disciplinary teams" to "provide optimised treatments faster". Josh McComack, Imaging Biometrics' director of software engineering, says the new installation "demonstrates that IB Nimble is ready for widespread deployment."

Latest Share Chat

Iq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account